Meurens François, Schynts Frédéric, Keil Günther M, Muylkens Benoît, Vanderplasschen Alain, Gallego Pierre, Thiry Etienne
Department of Infectious and Parasitic Diseases, Virology, and Immunology, Faculty of Veterinary Medicine, University of Liège, B-4000 Liège, Belgium.
J Virol. 2004 Apr;78(8):3872-9. doi: 10.1128/jvi.78.8.3872-3879.2004.
Homologous recombination between strains of the same alphaherpesvirus species occurs frequently both in vitro and in vivo. This process has been described between strains of herpes simplex virus type 1, herpes simplex virus type 2, pseudorabies virus, feline herpesvirus 1, varicella-zoster virus, and bovine herpesvirus 1 (BoHV-1). In vivo, the rise of recombinant viruses can be modulated by different factors, such as the dose of the inoculated viruses, the distance between inoculation sites, the time interval between inoculation of the first and the second virus, and the genes in which the mutations are located. The effect of the time interval between infections with two distinguishable BoHV-1 on recombination was studied in three ways: (i) recombination at the level of progeny viruses, (ii) interference induced by the first virus infection on beta-galactosidase gene expression of a superinfecting virus, and (iii) recombination at the level of concatemeric DNA. A time interval of 2 to 8 h between two successive infections allows the establishment of a barrier, which reduces or prevents any successful superinfection needed to generate recombinant viruses. The dramatic effect of the time interval on the rise of recombinant viruses is particularly important for the risk assessment of recombination between glycoprotein E-negative marker vaccine and field strains that could threaten BoHV-1 control and eradication programs.
同一α疱疹病毒种的不同毒株之间的同源重组在体外和体内均频繁发生。这一过程已在1型单纯疱疹病毒、2型单纯疱疹病毒、伪狂犬病病毒、猫疱疹病毒1型、水痘-带状疱疹病毒和牛疱疹病毒1型(BoHV-1)的不同毒株之间得到描述。在体内,重组病毒的出现可受到不同因素的调节,如接种病毒的剂量、接种部位之间的距离、首次和第二次接种病毒的时间间隔以及发生突变的基因。我们通过三种方式研究了两种可区分的BoHV-1感染之间的时间间隔对重组的影响:(i)子代病毒水平的重组;(ii)第一次病毒感染对超感染病毒β-半乳糖苷酶基因表达的干扰;(iii)串联DNA水平的重组。连续两次感染之间2至8小时的时间间隔会形成一道屏障,减少或阻止产生重组病毒所需的任何成功的超感染。时间间隔对重组病毒出现的显著影响对于评估糖蛋白E阴性标记疫苗与可能威胁BoHV-1控制和根除计划的野毒株之间重组的风险尤为重要。